Global Radiopharmaceutical Theranostics Market Industry Analysis 2021-2031, Featuring Nihon Medi-Physics, Telix Pharmaceuticals, GE Healthcare, Curium Pharma and Bayer - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Radiopharmaceutical Theranostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

This report studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global radiopharmaceutical theranostics market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global radiopharmaceutical theranostics market from 2021 to 2031.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global radiopharmaceutical theranostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global radiopharmaceutical theranostics market.

The report delves into the competitive landscape of the global radiopharmaceutical theranostics market. Key players operating in the global radiopharmaceutical theranostics market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global radiopharmaceutical theranostics market profiled in this report.

Key Questions Answered

• What is the sales/revenue generated by the radiopharmaceutical theranostics market across all regions during the forecast period?
• What are the opportunities in the global radiopharmaceutical theranostics market?
• What are the major drivers, restraints, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

   

The report analyzes the global radiopharmaceutical theranostics market in terms of radioisotope, application, source, end user, approach, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global radiopharmaceutical theranostics market.

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Radiopharmaceutical Theranostics Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.4. Global Radiopharmaceutical Theranostics Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Overview of Radiopharmaceuticals market

5.2. FDA Approved Radiopharmaceuticals Products

5.3. Overview of Radiopharamceutical Diagnostic Market

5.4. Overview of Radiopharamceutical Therapy Market

5.5. Regulatory Scenario

5.6. Current and Future Radiopharmaceutical Theranostics Pairs

5.7. COVID-19 Impact Analysis

6. Global Radiopharmaceutical Theranostics Market Analysis and Forecast, by Radioisotope

6.1. Introduction & Definition

6.2. Key Findings/Developments

6.3. Market Value Forecast, by Radioisotope, 2017-2031

6.4. Market Attractiveness Analysis, by Radioisotope

7. Global Radiopharmaceutical Theranostics Market Analysis and Forecast, by Application

8. Global Radiopharmaceutical Theranostics Market Analysis and Forecast, by Source

9. Global Radiopharmaceutical Theranostics Market Analysis and Forecast, by Approach

10. Global Radiopharmaceutical Theranostics Market Analysis and Forecast, by End-user

11. Global Radiopharmaceutical Theranostics Market Analysis and Forecast, by Region

12. North America Radiopharmaceutical Theranostics Market Analysis and Forecast

13. Europe Radiopharmaceutical Theranostics Market Analysis and Forecast

14. Asia Pacific Radiopharmaceutical Theranostics Market Analysis and Forecast

15. Latin America Radiopharmaceutical Theranostics Market Analysis and Forecast

16. Middle East & Africa Radiopharmaceutical Theranostics Market Analysis and Forecast

17. Competition Landscape

• Nihon Medi-Physics
• ITM Isotopen Technologien Munchen AG
• Advanced Accelerator Applications
• Telix Pharmaceuticals
• GE Healthcare
• Theragnostics Ltd
• NuView Life Sciences
• Jubilant Pharma Limited
• Lantheus Holdings, Inc.
• Curium Pharma
• Bayer AG
• Clarity Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/xkvnfn

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.